Evidence map›Paper›PMID 25732192›Full record

ArticleDiabetes2015

Adenylyl Cyclase Type 5 Deficiency Protects Against Diet-Induced Obesity and Insulin Resistance.

David Ho, Xin Zhao, Lin Yan, Chujun Yuan, Haihong Zong, Dorothy E Vatner, Jeffery E Pessin, Stephen F Vatner

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Mechanisms of Abnormal Lipid Metabolism in the Pathogenesis of Disease.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Effects of Whole-Body Adenylyl Cyclase 5 (International journal of molecular sciences · 2021
    Article
  10. Article
  11. CRISPR/Cas9Frontiers in endocrinology · 2021
    Article
  12. Review
  13. Article
  14. Adenylyl cyclase 6 is required for maintaining acid-base homeostasis.Clinical science (London, England : 1979) · 2018
    Article
  15. Rimonabant improves metabolic parameters partially attributed to restoration of high voltage-activated Ca2+ channels in skeletal muscle in HFD-fed mice.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2017
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

David HoDepartments of Cell Biology and Molecular Medicine and Medicine, New Jersey Medical School, Rutgers University, Newark, NJ.
Xin ZhaoDepartments of Cell Biology and Molecular Medicine and Medicine, New Jersey Medical School, Rutgers University, Newark, NJ.
Lin YanDepartments of Cell Biology and Molecular Medicine and Medicine, New Jersey Medical School, Rutgers University, Newark, NJ.
Chujun YuanDepartments of Cell Biology and Molecular Medicine and Medicine, New Jersey Medical School, Rutgers University, Newark, NJ.
Haihong ZongDepartments of Medicine and Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY.
Dorothy E VatnerDepartments of Cell Biology and Molecular Medicine and Medicine, New Jersey Medical School, Rutgers University, Newark, NJ.
Jeffery E PessinDepartments of Medicine and Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY.
Stephen F VatnerDepartments of Cell Biology and Molecular Medicine and Medicine, New Jersey Medical School, Rutgers University, Newark, NJ vatnersf@njms.rutgers.edu.
Rutgers, The State University of New Jersey · USAlbert Einstein College of Medicine · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
RESEARCH TRAININGP30DK026687 · NIDDK · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI Anthony W Ferrante, DYMPNA GALLAGHER · 1986 to 2026
$33.0M
Stable Isotope and Metabolomics CoreP60DK020541 · NIDDK · YESHIVA UNIVERSITY · PI FLEISCHER, NORMAN S. · 1986 to 2014
$29.8M
Molecular Mechanisms in Chronically Stunned MyocardiumP01HL069020 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, DOROTHY EILEEN · 2001 to 2014
$21.3M
Longevity and Stress ResistanceP01AG027211 · NIA · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 2007 to 2013
$10.3M
REGULATION OF THE INSULIN RECEPTOR KINASER01DK033823 · NIDDK · UNIVERSITY OF IOWA · PI KURLAND, IRWIN JACK, PESSIN, JEFFREY E. · 1986 to 2022
$6.7M
CARDIOVASCULAR CONTROL IN NORMAL AND DISEASE STATESR01HL033107 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 1985 to 2011
$6.2M
Intracellular signaling by the insulin receptor kinaseR37DK033823 · NIDDK · STATE UNIVERSITY NEW YORK STONY BROOK · PI PESSIN, JEFFREY E. · 2005 to 2014
$4.2M
Regulation of Brown Fat Development and Function by Cyclin CR01DK098439 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI PESSIN, JEFFREY E., YANG, FAJUN JAMES · 2013 to 2021
$3.8M
Skeletal Muscle Basis for Improved Exercise Endurance in RGS14 KOR01HL106511 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 2011 to 2019
$3.8M
Integrative Mechanisms in Cardiovascular DiseaseT32HL069752 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 2004 to 2013
$2.9M
Intrinsic Vascular Smooth Muscle Cell StiffnessR01HL102472 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 2010 to 2016
$2.5M
NCI NIH HHS P30 CA013330NHLBI NIH HHS 1-R01-HL-102472NHLBI NIH HHS 1-R01-HL-119464NHLBI NIH HHS 5-P01-HL-069020NHLBI NIH HHS 5-R01-HL-033107NHLBI NIH HHS 5-R01-HL-091781NHLBI NIH HHS 5-R01-HL-095888NHLBI NIH HHS 5-R21-HL-097264NHLBI NIH HHS 5-T32-HL-069752NHLBI NIH HHS P01 HL069020NHLBI NIH HHS R01 HL033107NHLBI NIH HHS R01 HL091781NHLBI NIH HHS R01 HL093481NHLBI NIH HHS R01-HL-093481NHLBI NIH HHS R01 HL095888NHLBI NIH HHS R01 HL102472NHLBI NIH HHS R01 HL106511NHLBI NIH HHS R01-HL-106511NHLBI NIH HHS R01 HL119464NHLBI NIH HHS R21 HL097264NHLBI NIH HHS T32 HL069752NIA NIH HHS 5-P01-AG-027211NIA NIH HHS P01 AG027211NIDDK NIH HHS 5-R37-DK-033823NIDDK NIH HHS P30 DK026687NIDDK NIH HHS P60 DK020541NIDDK NIH HHS P60-DK-020541NIDDK NIH HHS R01 DK033823NIDDK NIH HHS R01 DK098439NIDDK NIH HHS R37 DK033823
6 · The paper itself

Abstract

Adenylyl cyclase type 5 knockout (AC5KO) mice have increased longevity and share a similar phenotype with calorie-restricted wild-type (WT) mice. To determine the in vivo metabolic properties of AC5 deficiency, we compared the effects of standard diet (SD) and high-fat diet (HFD) on obesity, energy balance, glucose regulation, and insulin sensitivity. AC5KO mice on SD had reduced body weight and adiposity compared with WT mice. Blood cholesterol and triglyceride levels were also significantly reduced in AC5KO mice. Indirect calorimetry demonstrated increased oxygen consumption, respiratory exchange ratio, and energy expenditure in AC5KO compared with WT mice on both SD and HFD. AC5KO mice also displayed improved glucose tolerance and increased whole-body insulin sensitivity, accompanied by decreased liver glycogen stores. Euglycemic-hyperinsulinemic clamp studies confirmed the marked improvement of glucose homeostasis and insulin sensitivity in AC5KO mice primarily through increased insulin sensitivity in skeletal muscle. Moreover, the genes involved in mitochondrial biogenesis and function were significantly increased in AC5KO skeletal muscle. These data demonstrate that deficiency of AC5 protects against obesity, glucose intolerance, and insulin resistance, supporting AC5 as a potential novel therapeutic target for treatment of obesity and diabetes.

Indexed as

Insulin ResistanceAdenylyl Cyclase InhibitorsAdenylyl CyclasesAnimalsDiet, High-FatEnergy MetabolismMiceMice, Inbred C57BLMice, KnockoutMuscle, SkeletalObesityAdenylyl Cyclase InhibitorsAdenylyl Cyclasesadenylyl cyclase type V

Identifiers

PMID25732192
PMCPMC4477357
OpenAlexW1988758413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.